LEADER 00000nam  22002658a 4500 
001    99015991800 
003    UkLCURL 
008    111205s2012    nyu           000 0 eng|d 
020    9781461423997|q(hbk.) 
020    1461423996|q(hbk.) 
035    (Uk)015991800 
040    StDuBDS|beng|cStDuBDS 
049    |jCU|k99015991800|lb|m- 
050  4 RC 280 K5 R3 
082 04 616.99461|223 
245 00 Renal cell carcinoma :|btranslational biology, 
       personalized medicine, and novel therapeutic targets /
       |cRobert A. Figlin, W. Kimryn Rathmell, Brian Rini, 
       editors. 
260    New York ;|aLondon :|bSpringer,|c2012. 
300    327p. 
650  0 Renal cell carcinoma. 
700 1  Figlin, Robert A. 
700 1  Rathmell, W. Kimryn. 
700 1  Rini, Brian I. 
LOCATION SHELVED AT LOAN TYPE STATUS
 BJL 3rd Floor  RC 280 K5 R3  8 WEEK LOAN  DUE 07-05-24